Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

AGEN Agenus Inc

6,67

0,17 (2,62%)

Vor Marktöffnung

Zuletzt aktualisiert: 14:02:36

Verzögert um 15 Minuten

Agenus, Targovax team up for mutant KRAS cancer vaccines

To read the full story on Seeking Alpha, click here.

Agenus (NASDAQ:AGEN)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Click Here for more Agenus Charts.

Agenus (NASDAQ:AGEN)
Historical Stock Chart
Von Apr 2023 bis Apr 2024

Click Here for more Agenus Charts.

News Agenus Inc

Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
Freitag 12 April 2024 (4 Tage vor) • Business Wire

Agenus Announces Reverse Stock Split of Common Stock
Freitag 5 April 2024 (2 Wochen vor) • Business Wire

Agenus Reports Fourth Quarter and Full Year 2023 Results
Donnerstag 14 März 2024 (1 Monat vor) • Business Wire

Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
Mittwoch 6 März 2024 (1 Monat vor) • Business Wire

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dienstag 5 März 2024 (1 Monat vor) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
Donnerstag 29 Februar 2024 (2 Monate vor) • Business Wire

Form DEF 14A - Other definitive proxy statements
Montag 26 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Agenus to Participate in Leerink Partners Global Biopharma Conference
Montag 26 Februar 2024 (2 Monate vor) • Business Wire

Form PRE 14A - Other preliminary proxy statements
Donnerstag 15 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 15 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design
Donnerstag 15 Februar 2024 (2 Monate vor) • PR Newswire (US)

Weitere Agenus Inc News-Artikel

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

BNP Paribas (QX)

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen